221 related articles for article (PubMed ID: 24713006)
1. Strategies to manage hepatitis C virus (HCV) disease burden.
Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz ML; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus AL; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E
J Viral Hepat; 2014 May; 21 Suppl 1():60-89. PubMed ID: 24713006
[TBL] [Abstract][Full Text] [Related]
2. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz ML; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus AL; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C
J Viral Hepat; 2014 May; 21 Suppl 1():34-59. PubMed ID: 24713005
[TBL] [Abstract][Full Text] [Related]
3. Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.
Gane E; Kershenobich D; Seguin-Devaux C; Kristian P; Aho I; Dalgard O; Shestakova I; Nymadawa P; Blach S; Acharya S; Anand AC; Andersson MI; Arendt V; Arkkila P; Baatarkhuu O; Barclay K; Ben-Ari Z; Bergin C; Bessone F; Blokhina N; Brunton CR; Choudhuri G; Chulanov V; Cisneros L; Croes EA; Dahgwahdorj YA; Daruich JR; Dashdorj NR; Davaadorj D; de Knegt RJ; de Vree M; Gadano AC; Gower E; Halota W; Hatzakis A; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kostrzewska K; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Mossong J; Norris S; Nurmukhametova E; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prins M; Puri P; Radke S; Rakhmanova A; Razavi H; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanchez Avila JF; Sanduijav R; Saraswat V; Schréter I; Shah SR; Shevaldin A; Shibolet O; Silva MO; Sokolov S; Sonderup M; Souliotis K; Spearman CW; Staub T; Stedman C; Strebkova EA; Struck D; Sypsa V; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuckerman E; Zuure FR; Prabdial-Sing N; Flisiak R; Estes C
J Viral Hepat; 2015 Jan; 22 Suppl 1():46-73. PubMed ID: 25560841
[TBL] [Abstract][Full Text] [Related]
4. Strategies to manage hepatitis C virus infection disease burden - volume 3.
Alfaleh FZ; Nugrahini N; Matičič M; Tolmane I; Alzaabi M; Hajarizadeh B; Valantinas J; Kim DY; Hunyady B; Abaalkhail F; Abbas Z; Abdou A; Abourached A; Al Braiki F; Al Hosani F; Al Jaberi K; Al Khatry M; Al Mulla MA; Al Quraishi H; Al Rifai A; Al Serkal Y; Alam A; Alashgar HI; Alavian SM; Alawadhi S; Al-Dabal L; Aldins P; Alghamdi AS; Al-Hakeem R; Aljumah AA; Almessabi A; Alqutub AN; Alswat KA; Altraif I; Andrea N; Assiri AM; Babatin MA; Baqir A; Barakat MT; Bergmann OM; Bizri AR; Chaudhry A; Choi MS; Diab T; Djauzi S; El Hassan ES; El Khoury S; Estes C; Fakhry S; Farooqi JI; Fridjonsdottir H; Gani RA; Ghafoor Khan A; Gheorghe L; Goldis A; Gottfredsson M; Gregorcic S; Gunter J; Hamid S; Han KH; Hasan I; Hashim A; Horvath G; Husni R; Jafri W; Jeruma A; Jonasson JG; Karlsdottir B; Kim YS; Koutoubi Z; Lesmana LA; Liakina V; Lim YS; Löve A; Maimets M; Makara M; Malekzadeh R; Memon MS; Merat S; Mokhbat JE; Mourad FH; Muljono DH; Nawaz A; Olafsson S; Priohutomo S; Qureshi H; Rassam P; Razavi H; Razavi-Shearer D; Razavi-Shearer K; Rozentale B; Sadik M; Saeed K; Salamat A; Salupere R; Sanai FM; Sanityoso Sulaiman A; Sayegh RA; Schmelzer JD; Sharara AI; Sibley A; Siddiq M; Siddiqui AM; Sigmundsdottir G; Sigurdardottir B; Speiciene D; Sulaiman A; Sultan MA; Taha M; Tanaka J; Tarifi H; Tayyab G; Ud Din M; Umar M; Videčnik-Zorman J; Yaghi C; Yunihastuti E; Yusuf MA; Zuberi BF; Blach S
J Viral Hepat; 2015 Dec; 22 Suppl 4():42-65. PubMed ID: 26513447
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
[TBL] [Abstract][Full Text] [Related]
6. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
[TBL] [Abstract][Full Text] [Related]
7. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.
Hatzakis A; Chulanov V; Gadano AC; Bergin C; Ben-Ari Z; Mossong J; Schréter I; Baatarkhuu O; Acharya S; Aho I; Anand AC; Andersson MI; Arendt V; Arkkila P; Barclay K; Bessone F; Blach S; Blokhina N; Brunton CR; Choudhuri G; Cisneros L; Croes EA; Dahgwahdorj YA; Dalgard O; Daruich JR; Dashdorj NR; Davaadorj D; de Knegt RJ; de Vree M; Estes C; Flisiak R; Gane E; Gower E; Halota W; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kershenobich D; Kostrzewska K; Kristian P; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Norris S; Nurmukhametova E; Nymadawa P; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prabdial-Sing N; Prins M; Radke S; Rakhmanova A; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanchez Avila JF; Sanduijav R; Saraswat V; Seguin-Devaux C; Shah SR; Shestakova I; Shevaldin A; Shibolet O; Silva MO; Sokolov S; Sonderup M; Souliotis K; Spearman CW; Staub T; Stedman C; Strebkova EA; Struck D; Sypsa V; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuckerman E; Zuure FR; Puri P; Razavi H
J Viral Hepat; 2015 Jan; 22 Suppl 1():26-45. PubMed ID: 25560840
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).
Dore GJ; Ward J; Thursz M
J Viral Hepat; 2014 May; 21 Suppl 1():1-4. PubMed ID: 24713003
[TBL] [Abstract][Full Text] [Related]
9. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.
Sibley A; Han KH; Abourached A; Lesmana LA; Makara M; Jafri W; Salupere R; Assiri AM; Goldis A; Abaalkhail F; Abbas Z; Abdou A; Al Braiki F; Al Hosani F; Al Jaberi K; Al Khatry M; Al Mulla MA; Al Quraishi H; Al Rifai A; Al Serkal Y; Alam A; Alavian SM; Alashgar HI; Alawadhi S; Al-Dabal L; Aldins P; Alfaleh FZ; Alghamdi AS; Al-Hakeem R; Aljumah AA; Almessabi A; Alqutub AN; Alswat KA; Altraif I; Alzaabi M; Andrea N; Babatin MA; Baqir A; Barakat MT; Bergmann OM; Bizri AR; Blach S; Chaudhry A; Choi MS; Diab T; Djauzi S; El Hassan ES; El Khoury S; Estes C; Fakhry S; Farooqi JI; Fridjonsdottir H; Gani RA; Ghafoor Khan A; Gheorghe L; Gottfredsson M; Gregorcic S; Gunter J; Hajarizadeh B; Hamid S; Hasan I; Hashim A; Horvath G; Hunyady B; Husni R; Jeruma A; Jonasson JG; Karlsdottir B; Kim DY; Kim YS; Koutoubi Z; Liakina V; Lim YS; Löve A; Maimets M; Malekzadeh R; Matičič M; Memon MS; Merat S; Mokhbat JE; Mourad FH; Muljono DH; Nawaz A; Nugrahini N; Olafsson S; Priohutomo S; Qureshi H; Rassam P; Razavi H; Razavi-Shearer D; Razavi-Shearer K; Rozentale B; Sadik M; Saeed K; Salamat A; Sanai FM; Sanityoso Sulaiman A; Sayegh RA; Sharara AI; Siddiq M; Siddiqui AM; Sigmundsdottir G; Sigurdardottir B; Speiciene D; Sulaiman A; Sultan MA; Taha M; Tanaka J; Tarifi H; Tayyab G; Tolmane I; Ud Din M; Umar M; Valantinas J; Videčnik-Zorman J; Yaghi C; Yunihastuti E; Yusuf MA; Zuberi BF; Schmelzer JD
J Viral Hepat; 2015 Dec; 22 Suppl 4():21-41. PubMed ID: 26513446
[TBL] [Abstract][Full Text] [Related]
10. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.
Saraswat V; Norris S; de Knegt RJ; Sanchez Avila JF; Sonderup M; Zuckerman E; Arkkila P; Stedman C; Acharya S; Aho I; Anand AC; Andersson MI; Arendt V; Baatarkhuu O; Barclay K; Ben-Ari Z; Bergin C; Bessone F; Blach S; Blokhina N; Brunton CR; Choudhuri G; Chulanov V; Cisneros L; Croes EA; Dahgwahdorj YA; Dalgard O; Daruich JR; Dashdorj NR; Davaadorj D; de Vree M; Estes C; Flisiak R; Gadano AC; Gane E; Halota W; Hatzakis A; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kershenobich D; Kostrzewska K; Kristian P; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Mossong J; Nurmukhametova E; Nymadawa P; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prabdial-Sing N; Prins M; Puri P; Radke S; Rakhmanova A; Razavi H; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanduijav R; Schréter I; Seguin-Devaux C; Shah SR; Shestakova I; Shevaldin A; Shibolet O; Sokolov S; Souliotis K; Spearman CW; Staub T; Strebkova EA; Struck D; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuure FR; Silva MO; Sypsa V; Gower E
J Viral Hepat; 2015 Jan; 22 Suppl 1():6-25. PubMed ID: 25560839
[TBL] [Abstract][Full Text] [Related]
11. Historical epidemiology of hepatitis C virus (HCV) in selected countries.
Bruggmann P; Berg T; Øvrehus AL; Moreno C; Brandão Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balık I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Estes C; Falconer K; Félix J; Ferraz ML; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hézode C; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marotta P; Mauss S; Mendes Correa MC; Müllhaupt B; Myers RP; Negro F; Nemecek V; Örmeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ
J Viral Hepat; 2014 May; 21 Suppl 1():5-33. PubMed ID: 24713004
[TBL] [Abstract][Full Text] [Related]
12. HCV burden in Europe and the possible impact of current treatment.
Mathurin P
Dig Liver Dis; 2013 Sep; 45 Suppl 5():S314-7. PubMed ID: 24091109
[TBL] [Abstract][Full Text] [Related]
13. Estimates on HCV disease burden worldwide - filling the gaps.
Wedemeyer H; Dore GJ; Ward JW
J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
[TBL] [Abstract][Full Text] [Related]
14. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
Willemse SB; Razavi-Shearer D; Zuure FR; Veldhuijzen IK; Croes EA; van der Meer AJ; van Santen DK; de Vree JM; de Knegt RJ; Zaaijer HL; Reesink HW; Prins M; Razavi H
Neth J Med; 2015 Nov; 73(9):417-31. PubMed ID: 26582807
[TBL] [Abstract][Full Text] [Related]
15. Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
Gane E; Stedman C; Brunton C; Radke S; Henderson C; Estes C; Razavi H
N Z Med J; 2014 Dec; 127(1407):61-74. PubMed ID: 25530333
[TBL] [Abstract][Full Text] [Related]
16. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.
Liakina V; Hamid S; Tanaka J; Olafsson S; Sharara AI; Alavian SM; Gheorghe L; El Hassan ES; Abaalkhail F; Abbas Z; Abdou A; Abourached A; Al Braiki F; Al Hosani F; Al Jaberi K; Al Khatry M; Al Mulla MA; Al Quraishi H; Al Rifai A; Al Serkal Y; Alam A; Alashgar HI; Alawadhi S; Al-Dabal L; Aldins P; Alfaleh FZ; Alghamdi AS; Al-Hakeem R; Aljumah AA; Almessabi A; Alqutub AN; Alswat KA; Altraif I; Alzaabi M; Andrea N; Assiri AM; Babatin MA; Baqir A; Barakat MT; Bergmann OM; Bizri AR; Blach S; Chaudhry A; Choi MS; Diab T; Djauzi S; El Khoury S; Estes C; Fakhry S; Farooqi JI; Fridjonsdottir H; Gani RA; Ghafoor Khan A; Goldis A; Gottfredsson M; Gregorcic S; Hajarizadeh B; Han KH; Hasan I; Hashim A; Horvath G; Hunyady B; Husni R; Jafri W; Jeruma A; Jonasson JG; Karlsdottir B; Kim DY; Kim YS; Koutoubi Z; Lesmana LA; Lim YS; Löve A; Maimets M; Makara M; Malekzadeh R; Matičič M; Memon MS; Merat S; Mokhbat JE; Mourad FH; Muljono DH; Nawaz A; Nugrahini N; Priohutomo S; Qureshi H; Rassam P; Razavi H; Razavi-Shearer D; Razavi-Shearer K; Rozentale B; Sadik M; Saeed K; Salamat A; Salupere R; Sanai FM; Sanityoso Sulaiman A; Sayegh RA; Schmelzer JD; Sibley A; Siddiq M; Siddiqui AM; Sigmundsdottir G; Sigurdardottir B; Speiciene D; Sulaiman A; Sultan MA; Taha M; Tarifi H; Tayyab G; Tolmane I; Ud Din M; Umar M; Valantinas J; Videčnik-Zorman J; Yaghi C; Yunihastuti E; Yusuf MA; Zuberi BF; Gunter J
J Viral Hepat; 2015 Dec; 22 Suppl 4():4-20. PubMed ID: 26513445
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.
Durham DP; Skrip LA; Bruce RD; Vilarinho S; Elbasha EH; Galvani AP; Townsend JP
Clin Infect Dis; 2016 Feb; 62(3):298-304. PubMed ID: 26628566
[TBL] [Abstract][Full Text] [Related]
18. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
19. Predicted effects of treatment for HCV infection vary among European countries.
Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
[TBL] [Abstract][Full Text] [Related]
20. Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.
Kershenobich D; Razavi HA; Cooper CL; Alberti A; Dusheiko GM; Pol S; Zuckerman E; Koike K; Han KH; Wallace CM; Zeuzem S; Negro F
Liver Int; 2011 Jul; 31 Suppl 2():4-17. PubMed ID: 21651700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
